These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14758783)

  • 21. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications.
    Gaspar PA; Bustamante ML; Silva H; Aboitiz F
    J Neurochem; 2009 Nov; 111(4):891-900. PubMed ID: 19686383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of glutamatergic transmission by 3,5-dibromo-L-phenylalanine.
    Yarotskyy V; Glushakov AV; Sumners C; Gravenstein N; Dennis DM; Seubert CN; Martynyuk AE
    Mol Pharmacol; 2005 May; 67(5):1648-54. PubMed ID: 15687225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex.
    Ohnuma T; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):889-94. PubMed ID: 15949884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study.
    Gulli R; Masnata B; Bonvicini C; Tura GB; Manglaviti L; Vaggi M; Mollica M; Bellone E; Mandich P; Gennarelli M; Di Maria E
    Psychiatr Genet; 2007 Dec; 17(6):355-6. PubMed ID: 18075478
    [No Abstract]   [Full Text] [Related]  

  • 25. [Genetic hypothesis of schizophrenia].
    Krebs MO
    Rev Prat; 2002 Jun; 52(11):1208-11. PubMed ID: 12148206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Involvement of central neurotransmission systems in schizophrenia].
    Martres MP
    Therapie; 2008; 63(3):177-85. PubMed ID: 18718209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia susceptibility genes: emergence of positional candidates and future directions.
    Gogos JA; Gerber DJ
    Trends Pharmacol Sci; 2006 Apr; 27(4):226-33. PubMed ID: 16530856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia.
    MacDonald AW; Chafee MV
    Dev Psychopathol; 2006; 18(3):853-76. PubMed ID: 17152404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of animal models for schizophrenia based on clinical evidence: expectation for psychiatrists].
    Noda Y; Mouri A; Waki Y; Nabeshima T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):47-53. PubMed ID: 19562941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schizophrenia: genes at last?
    Owen MJ; Craddock N; O'Donovan MC
    Trends Genet; 2005 Sep; 21(9):518-25. PubMed ID: 16009449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
    Woo TU; Walsh JP; Benes FM
    Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The GABA-glutamate connection in schizophrenia: which is the proximate cause?
    Coyle JT
    Biochem Pharmacol; 2004 Oct; 68(8):1507-14. PubMed ID: 15451393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular genetics of schizophrenia: new findings promise new insights.
    Owen MJ; Williams NM; O'Donovan MC
    Mol Psychiatry; 2004 Jan; 9(1):14-27. PubMed ID: 14581932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.
    Yamada K; Ohnishi T; Hashimoto K; Ohba H; Iwayama-Shigeno Y; Toyoshima M; Okuno A; Takao H; Toyota T; Minabe Y; Nakamura K; Shimizu E; Itokawa M; Mori N; Iyo M; Yoshikawa T
    Biol Psychiatry; 2005 Jun; 57(12):1493-503. PubMed ID: 15953485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chasing genes for mood disorders and schizophrenia in genetically isolated populations.
    Venken T; Del-Favero J
    Hum Mutat; 2007 Dec; 28(12):1156-70. PubMed ID: 17659644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain.
    Long KD; Mastropaolo J; Rosse RB; Manaye KF; Deutsch SI
    Brain Res Bull; 2006 May; 69(6):626-30. PubMed ID: 16716829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiologically based treatment interventions in schizophrenia.
    Lewis DA; Gonzalez-Burgos G
    Nat Med; 2006 Sep; 12(9):1016-22. PubMed ID: 16960576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs.
    Fumagalli F; Frasca A; Racagni G; Riva MA
    Mol Pharmacol; 2008 May; 73(5):1484-90. PubMed ID: 18250147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA receptors and schizophrenia.
    Kristiansen LV; Huerta I; Beneyto M; Meador-Woodruff JH
    Curr Opin Pharmacol; 2007 Feb; 7(1):48-55. PubMed ID: 17097347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.